COLL logo

Collegium Pharmaceutical (COLL) Cash From Investing

Annual CFI

-$70.81 M
+$502.88 M+87.66%

December 31, 2023

Summary

Performance

1-Year Change

+87.66%

3-Year Change

+81.05%

5-Year Change

-190.76%

15-Year Change

-7052.73%

COLL Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

16.23%
COLL annual cash flow from investing activities is higher than 16.23% of companies in Healthcare sector

High & Low

All-time High

-$8000.00

3-Year Low

-$573.69 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
COLL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 21, 2025
COLL next annual earnings announcement is scheduled for Feb 21, 2025

OtherCOLLcash flowmetrics:

Annual CFF

-$140.18 M
COLL annual cash flow from financing activities is -$140.18 million

Annual CFO

$274.75 M
COLL annual cash flow from operations is $274.75 million

Annual FCF

$274.29 M
COLL annual free cash flow is $274.29 million

Annual CAPEX

$461.00 K
COLL annual capital expenditures is $461.00 thousand

Quarterly CFI

-$248.96 M
-$240.06 M-2695.45%

September 30, 2024

Summary

Performance

3-Month Change

-2695.45%

1-Year Change

-6413.95%

3-Year Change

-6413.95%

5-Year Change

-6413.95%

COLL Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

3.46%
COLL quarterly cash flow from investing activities is higher than 3.46% of companies in Healthcare sector

High & Low

All-time High

$0.00
COLL quarterly cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$572.18 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
COLL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
COLL next earnings announcement is scheduled for Feb 21, 2025

OtherCOLLcash flowmetrics:

Quarterly CFF

$149.03 M
COLL quarterly cash flow from financing activities is $149.03 million

Quarterly CFO

-$9.00 M
COLL quarterly cash flow from operations is -$9.00 million

Quarterly FCF

-$9.24 M
COLL quarterly free cash flow is -$9.24 million

Quarterly CAPEX

$244.00 K
COLL quarterly capital expenditures is $244.00 thousand

TTM CFI

-$301.09 M
-$245.14 M-438.12%

September 30, 2024

Summary

Performance

3-Month Change

-438.12%

1-Year Change

-545.36%

3-Year Change

-545.36%

5-Year Change

-545.36%

COLL TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.37%
COLL TTM cash flow from investing activities is higher than 8.37% of companies in Healthcare sector

High & Low

All-time High

$0.00
COLL TTM cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$573.69 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
COLL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
COLL next earnings announcement is scheduled for Feb 21, 2025

OtherCOLLcash flowmetrics:

TTM CFF

-$87.15 M
COLL TTM cash flow from financing activities is -$87.15 million

TTM CFO

$193.67 M
COLL TTM cash flow from operations is $193.67 million

TTM FCF

$192.43 M
COLL TTM free cash flow is $192.43 million

TTM CAPEX

$1.25 M
COLL TTM capital expenditures is $1.25 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

COLL Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+87.7%-6413.9%-545.4%
3 y3 years+81.0%-6413.9%-545.4%
5 y5 years-190.8%-6413.9%-545.4%

COLL Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3542.6%+87.7%<-9999.0%+56.5%<-9999.0%+47.5%
5 y5-year-3542.6%+87.7%<-9999.0%+56.5%<-9999.0%+47.5%
alltimeall time<-9999.0%+87.7%<-9999.0%+56.5%<-9999.0%+47.5%

Collegium Pharmaceutical Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$248.96 M(+2695.5%)
-$301.09 M(+438.1%)
Jun 2024
-
-$8.91 M(-50.9%)
-$55.95 M(-37.0%)
Mar 2024
-
-$18.13 M(-27.8%)
-$88.76 M(+25.4%)
Dec 2023
-$70.81 M(-87.7%)
-$25.10 M(+556.6%)
-$70.81 M(+51.8%)
Sep 2023
-
-$3.82 M(-90.8%)
-$46.66 M(+8.6%)
Jun 2023
-
-$41.72 M(>+9900.0%)
-$42.95 M(+2441.2%)
Mar 2023
-
-$176.00 K(-81.3%)
-$1.69 M(-99.7%)
Dec 2022
-$573.69 M(>+9900.0%)
-$940.00 K(+731.9%)
-$573.69 M(+0.1%)
Sep 2022
-
-$113.00 K(-75.5%)
-$573.27 M(-0.0%)
Jun 2022
-
-$461.00 K(-99.9%)
-$573.43 M(-0.0%)
Mar 2022
-
-$572.18 M(>+9900.0%)
-$573.69 M(>+9900.0%)
Dec 2021
-$1.94 M(-99.5%)
-$515.00 K(+86.6%)
-$1.94 M(-33.2%)
Sep 2021
-
-$276.00 K(-61.9%)
-$2.91 M(-42.2%)
Jun 2021
-
-$725.00 K(+69.4%)
-$5.04 M(-23.1%)
Mar 2021
-
-$428.00 K(-71.1%)
-$6.55 M(-98.2%)
Dec 2020
-$373.77 M(+5705.7%)
-$1.48 M(-38.4%)
-$373.77 M(+0.2%)
Sep 2020
-
-$2.40 M(+7.2%)
-$373.18 M(+0.3%)
Jun 2020
-
-$2.24 M(-99.4%)
-$372.13 M(+0.4%)
Mar 2020
-
-$367.65 M(>+9900.0%)
-$370.76 M(+5659.0%)
Dec 2019
-$6.44 M
-$889.00 K(-34.2%)
-$6.44 M(-12.1%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$1.35 M(+54.4%)
-$7.32 M(-15.7%)
Jun 2019
-
-$875.00 K(-73.7%)
-$8.69 M(+1.5%)
Mar 2019
-
-$3.32 M(+87.4%)
-$8.56 M(-64.9%)
Dec 2018
-$24.35 M(+2360.0%)
-$1.77 M(-34.7%)
-$24.35 M(+7.0%)
Sep 2018
-
-$2.72 M(+263.7%)
-$22.75 M(+11.7%)
Jun 2018
-
-$747.00 K(-96.1%)
-$20.38 M(+1.5%)
Mar 2018
-
-$19.12 M(>+9900.0%)
-$20.08 M(+1928.1%)
Dec 2017
-$990.00 K(-66.7%)
-$172.00 K(-49.4%)
-$990.00 K(-14.6%)
Sep 2017
-
-$340.00 K(-24.3%)
-$1.16 M(+24.6%)
Jun 2017
-
-$449.00 K(+1448.3%)
-$930.00 K(-69.1%)
Mar 2017
-
-$29.00 K(-91.5%)
-$3.01 M(+1.0%)
Dec 2016
-$2.98 M(+722.4%)
-$341.00 K(+207.2%)
-$2.98 M(+5.5%)
Sep 2016
-
-$111.00 K(-95.6%)
-$2.82 M(-1.4%)
Jun 2016
-
-$2.52 M(+1250.3%)
-$2.86 M(+691.2%)
Dec 2015
-$362.00 K(+4425.0%)
-$187.00 K(+23.0%)
-$362.00 K(+97.8%)
Sep 2015
-
-$152.00 K(+560.9%)
-$183.00 K(+490.3%)
Jun 2015
-
-$23.00 K(+187.5%)
-$31.00 K(+287.5%)
Dec 2014
-$8000.00(-96.1%)
-$8000.00(<-9900.0%)
-$8000.00(<-9900.0%)
Jun 2014
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2014
-
$0.00
$0.00
Dec 2013
-$206.00 K
-
-

FAQ

  • What is Collegium Pharmaceutical annual cash flow from investing activities?
  • What is the all time high annual CFI for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical annual CFI year-on-year change?
  • What is Collegium Pharmaceutical quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical quarterly CFI year-on-year change?
  • What is Collegium Pharmaceutical TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical TTM CFI year-on-year change?

What is Collegium Pharmaceutical annual cash flow from investing activities?

The current annual CFI of COLL is -$70.81 M

What is the all time high annual CFI for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high annual cash flow from investing activities is -$8000.00

What is Collegium Pharmaceutical annual CFI year-on-year change?

Over the past year, COLL annual cash flow from investing activities has changed by +$502.88 M (+87.66%)

What is Collegium Pharmaceutical quarterly cash flow from investing activities?

The current quarterly CFI of COLL is -$248.96 M

What is the all time high quarterly CFI for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high quarterly cash flow from investing activities is $0.00

What is Collegium Pharmaceutical quarterly CFI year-on-year change?

Over the past year, COLL quarterly cash flow from investing activities has changed by -$245.14 M (-6413.95%)

What is Collegium Pharmaceutical TTM cash flow from investing activities?

The current TTM CFI of COLL is -$301.09 M

What is the all time high TTM CFI for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high TTM cash flow from investing activities is $0.00

What is Collegium Pharmaceutical TTM CFI year-on-year change?

Over the past year, COLL TTM cash flow from investing activities has changed by -$254.44 M (-545.36%)